Brain47Brain47Join Brain47
2CU

Chemours Co

Basic Materials · EUR · F

2CU

Price

€18.315

-3.02%

Cap

€3.46B

Earnings

—

30d Trend

-8.7%

2CU
Loading chart data...
0 days · % change from startPowered by Brain47
VolatilityHigh

74% annualised over 90 days

BRAIN47 SIGNAL

0
STRONG
Risk Level80
Quality49
Momentum83
Technical57
Fundamentals54

Raw weighted: 56×Macro 0.99 (−1%)=55

RISK

80/100
90d Volatility
74.1%High
ATR %
5.8%High daily moves
Max Drawdown (1Y)
-39.8%Volatile

QUALITY

49/100
Piotroski F-Score
5/9Average
Debt/Equity
16.40High leverage
Margin Stability
CV 7.3%Stable
Accruals
-8.8%Cash earnings

MOMENTUM

83/100
12-1M Momentum
+141.8%Strong uptrend
6-1M Momentum
+89.6%Positive
1M Return
-12.1%Sharp decline
Earnings Surprise
+400.0%Strong beat
Relative Strength
+3.5% vs sectorIn-line

TECHNICAL

57/100
RSI (14)
46.3Neutral
Price vs SMA200
+34.6%Bullish trend
MACD
-0.40Bearish momentum
Bollinger Band
31%Mid-range
SMA Cross
Death CrossDeath Cross
Trend Quality (KER)
0.167Noisy/choppy

FUNDAMENTALS

54/100
P/FCF
68.1Expensive
P/S
0.6Cheap
Shareholder Yield
4.2%Moderate

Macro: neutral (×0.99) - Fear/Greed: 65 (Greed) - Data: 100%

Running historical backtest...

BRAIN47 HORIZON ANALYSIS

<3 months38
3-12 months ★83
1-5+ years56

6-9 month momentum thesis — strong trend with confirmation

BRAIN47'S ASSESSMENT

I rate Chemours Co at 55/100 — a STRONG reading on the Brain47 Signal. The strongest factor is momentum at 83/100. I classify this as a growth position with the strongest thesis on a medium-term horizon.

PAST PERFORMANCE

1 MONTH

-12.1%

3 MONTHS

+23.8%

12 MONTHS

+129.7%

Trailing returns — past performance, not a projection.

DETAILED ANALYSIS

6-9 month momentum thesis — strong trend with confirmation. Momentum (83) and Technical (57) are the primary strengths. I note an elevated risk profile — this warrants closer monitoring. Historical volatility is elevated at 74%. I classify this as a growth position — strong momentum combined with growth potential points to capital appreciation.

growthScore: 55/100

Want full analysis on every stock?

Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.

Join Brain47 — Free

Generated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.